PHARMACOLOGY CMS NEWEST EXAMS WITH ACTUA COMPLETE
QUESTIONS AND CORRECT DETAILED ANSWERS.[ALREADY GRADED AN A+]
Question: A patient with chronic obstructive pulmonary disease (COPD) is being treated with a
long-acting beta-agonist (LABA) and an inhaled corticosteroid (ICS). The patient reports
increased shortness of breath and wheezing despite adhering to their medication regimen. What
is the most appropriate next step in the management of this patient?
A) Increase the dose of the LABA B) Add a long-acting muscarinic antagonist (LAMA) to the
regimen C) Switch to a different inhaled corticosteroid D) Recommend the use of a rescue
inhaler (SABA) as needed
Answer: B) Add a long-acting muscarinic antagonist (LAMA) to the regimen
Rationale: For patients with COPD who experience persistent symptoms despite being on a
LABA and ICS, adding a LAMA can provide additional symptom control. LAMAs work
through a different mechanism than LABAs and can help improve lung function and reduce
exacerbations. Increasing the dose of the LABA or switching the ICS may not address the
underlying issue as effectively as adding a LAMA. While a rescue inhaler (SABA) can help with
acute symptoms, it does not address the need for improved long-term management.
1.
Question: A patient with hypertension is prescribed lisinopril. What is the primary mechanism
of action for lisinopril?
A) Beta-adrenergic blockade
B) Inhibition of angiotensin-converting enzyme (ACE)
C) Calcium channel blockade
D) Diuretic effect
Answer: B) Inhibition of angiotensin-converting enzyme (ACE)
2.
Question: Which of the following medications is classified as a non-steroidal anti-inflammatory
drug (NSAID)?
A) Acetaminophen
B) Prednisone
C) Ibuprofen
D) Metformin
Answer: C) Ibuprofen
3.
QUESTIONS AND CORRECT DETAILED ANSWERS.[ALREADY GRADED AN A+]
Question: A patient with chronic obstructive pulmonary disease (COPD) is being treated with a
long-acting beta-agonist (LABA) and an inhaled corticosteroid (ICS). The patient reports
increased shortness of breath and wheezing despite adhering to their medication regimen. What
is the most appropriate next step in the management of this patient?
A) Increase the dose of the LABA B) Add a long-acting muscarinic antagonist (LAMA) to the
regimen C) Switch to a different inhaled corticosteroid D) Recommend the use of a rescue
inhaler (SABA) as needed
Answer: B) Add a long-acting muscarinic antagonist (LAMA) to the regimen
Rationale: For patients with COPD who experience persistent symptoms despite being on a
LABA and ICS, adding a LAMA can provide additional symptom control. LAMAs work
through a different mechanism than LABAs and can help improve lung function and reduce
exacerbations. Increasing the dose of the LABA or switching the ICS may not address the
underlying issue as effectively as adding a LAMA. While a rescue inhaler (SABA) can help with
acute symptoms, it does not address the need for improved long-term management.
1.
Question: A patient with hypertension is prescribed lisinopril. What is the primary mechanism
of action for lisinopril?
A) Beta-adrenergic blockade
B) Inhibition of angiotensin-converting enzyme (ACE)
C) Calcium channel blockade
D) Diuretic effect
Answer: B) Inhibition of angiotensin-converting enzyme (ACE)
2.
Question: Which of the following medications is classified as a non-steroidal anti-inflammatory
drug (NSAID)?
A) Acetaminophen
B) Prednisone
C) Ibuprofen
D) Metformin
Answer: C) Ibuprofen
3.
